Organisation paid for research Program year 2025 Source: CMS Open Payments

Advanced Uro PC

Neither a doctor nor a teaching hospital

Research payments

$455,182

78 payments

Through program year 2025, Advanced Uro PC is reported as receiving $455,182 in research payments, across 78 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2025	Research	$307,841	72
2024	Research	$147,341	6

Breakdown

Who paid Research payments · program years 2024–2025

Janssen Research & Development, LLC $455,182 78 payments

Studies the money was for Research payments · program years 2024–2025

A Study of TAR200 in Combination With Cetrelimab TAR200 Alone or Cetrelimab Alone in Participants With Non Muscle Invasive Bladder Cancer NMIBC Unresponsive to Intravesical Bacillus Calmette Guerin Who Are Ineligible for or Elected Not to Undergo Radical Cystectomy $271,537 54 payments
A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder (SunRISe-4) $88,768 17 payments
17000139Blc2002 $62,809 4 payments
A Study of TAR200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle invasive Bladder Cancer MIBC of the Bladder $32,068 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.